Home / Business and Economy / Jazz Pharma: Innovating Treatments for Sleep, Cancer & Pain
Jazz Pharma: Innovating Treatments for Sleep, Cancer & Pain
19 Nov, 2025
Summary
- Jazz Pharmaceuticals focuses on narcolepsy, oncology, pain, and psychiatry.
- Key products include Xyrem, Xywav, and Zepzelca.
- The company was founded in March 2003 and is based in Dublin, Ireland.
Jazz Pharmaceuticals Plc is a dynamic biopharmaceutical entity committed to the discovery, development, and commercialization of vital pharmaceutical products. The company's core focus areas include narcolepsy, oncology, pain management, and psychiatric disorders, addressing unmet medical needs.
Its extensive product pipeline boasts well-known treatments such as Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. These medications underscore Jazz Pharmaceuticals' dedication to improving patient outcomes in complex disease areas.
Established in March 2003, Jazz Pharmaceuticals operates with its headquarters situated in Dublin, Ireland. The company continues to advance its mission of developing innovative therapies for patients worldwide.
